Results 261 to 270 of about 197,632 (380)

Transcriptional and inflammasome‐mediated pathways for the induction of IL‐1β production by Mycobacterium tuberculosis

open access: bronze, 2009
Johanneke Kleinnijenhuis   +10 more
openalex   +1 more source

Chemical probing reveals insights into the signaling mechanism of inflammasome activation [PDF]

open access: bronze, 2010
Yi‐Nan Gong   +8 more
openalex   +1 more source

Oxidative Stress Modulation and Antileishmanial Activity of Salvinia auriculata

open access: yesChemistry &Biodiversity, EarlyView.
Ethanolic extract of Salvinia auriculata showed significant antioxidant and antileishmanial activities. Salviniside II, the major metabolite, was isolated, structurally characterized, and evaluated, but exhibited weaker antiparasitic effects when compared to the whole extract.
Augusto César Rodrigues   +6 more
wiley   +1 more source

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

open access: yesNature Immunology, 2008
V. Hornung   +7 more
semanticscholar   +1 more source

Comparative Analysis of Septin Modifiers, Forchlorfenuron and UR214‐9, on Mitochondrial Fragmentation and Lytic Cell Death

open access: yesCytoskeleton, EarlyView.
ABSTRACT Septins are conserved GTP‐binding proteins that play key roles in cell division, mitochondrial dynamics and immune responses. Despite their importance to human health, pharmacological compounds to modify septins remain limited. Forchlorfenuron (FCF) was the first small molecule identified to modify septins, disrupting their organisation and ...
Dominik Brokatzky   +4 more
wiley   +1 more source

Glyburide inhibits the Cryopyrin/Nalp3 inflammasome

open access: green, 2009
Mohamed Lamkanfi   +8 more
openalex   +2 more sources

Activation of the NLRP3 inflammasome by intracellular poly I:C [PDF]

open access: green, 2010
Jayant V. Rajan   +3 more
openalex   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy